We found that BDNF serumlevels are lower (13.7% less) and PAI-1 levels are higher (23% more)in Alzheimer patients with dementia than in Alzheimer patients withamnestic mild cognitive impairment patients. Here, BDNF is linked to Cognitive impairment.